These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cost-effectiveness analysis evaluating fidaxomicin versus oral vancomycin for the treatment of Clostridium difficile infection in the United States. Stranges PM, Hutton DW, Collins CD. Value Health; 2013; 16(2):297-304. PubMed ID: 23538181 [Abstract] [Full Text] [Related]
3. Fidaxomicin: a macrocyclic antibiotic for the treatment of Clostridium difficile infection. Hardesty JS, Juang P. Pharmacotherapy; 2011 Sep; 31(9):877-86. PubMed ID: 21923589 [Abstract] [Full Text] [Related]
4. Fidaxomicin: a minimally absorbed macrocyclic antibiotic for the treatment of Clostridium difficile infections. Soriano MM, Liao S, Danziger LH. Expert Rev Anti Infect Ther; 2013 Aug; 11(8):767-76. PubMed ID: 23977933 [Abstract] [Full Text] [Related]
6. Economic assessment of fidaxomicin for the treatment of Clostridium difficile infection (CDI) in special populations (patients with cancer, concomitant antibiotic treatment or renal impairment) in Spain. Rubio-Terrés C, Cobo Reinoso J, Grau Cerrato S, Mensa Pueyo J, Salavert Lletí M, Toledo A, Anguita P, Rubio-Rodríguez D, Watt M, Gani R. Eur J Clin Microbiol Infect Dis; 2015 Nov; 34(11):2213-23. PubMed ID: 26407619 [Abstract] [Full Text] [Related]
7. Fidaxomicin versus vancomycin for Clostridium difficile infection. Louie TJ, Miller MA, Mullane KM, Weiss K, Lentnek A, Golan Y, Gorbach S, Sears P, Shue YK, OPT-80-003 Clinical Study Group. N Engl J Med; 2011 Feb 03; 364(5):422-31. PubMed ID: 21288078 [Abstract] [Full Text] [Related]
8. Fidaxomicin: the newest addition to the armamentarium against Clostridium difficile infections. Lancaster JW, Matthews SJ. Clin Ther; 2012 Jan 03; 34(1):1-13. PubMed ID: 22284993 [Abstract] [Full Text] [Related]
10. Current and emerging management options for Clostridium difficile infection: what is the role of fidaxomicin? Cornely OA. Clin Microbiol Infect; 2012 Dec 03; 18 Suppl 6():28-35. PubMed ID: 23121552 [Abstract] [Full Text] [Related]
17. Fidaxomicin--the new drug for Clostridium difficile infection. Vaishnavi C. Indian J Med Res; 2015 Apr 03; 141(4):398-407. PubMed ID: 26112840 [Abstract] [Full Text] [Related]
18. Fidaxomicin: a novel macrocyclic antibiotic for the treatment of Clostridium difficile infection. Crawford T, Huesgen E, Danziger L. Am J Health Syst Pharm; 2012 Jun 01; 69(11):933-43. PubMed ID: 22610025 [Abstract] [Full Text] [Related]
19. Role of fidaxomicin for the treatment of Clostridium difficile infection. Juang P, Hardesty JS. J Pharm Pract; 2013 Oct 01; 26(5):491-7. PubMed ID: 24064437 [Abstract] [Full Text] [Related]
20. Fidaxomicin: a novel macrocyclic antibiotic approved for treatment of Clostridium difficile infection. Venugopal AA, Johnson S. Clin Infect Dis; 2012 Feb 15; 54(4):568-74. PubMed ID: 22156854 [Abstract] [Full Text] [Related] Page: [Next] [New Search]